Elucidating the precise pharmacological system of motion (MOA) of naturally occurring compounds is usually challenging. Whilst Tarselli et al. (60) formulated the very first de novo artificial pathway to conolidine and showcased that this naturally occurring compound proficiently suppresses responses to each chemically induced and inflammation-deri